{
  "title": "CannaTech Conference Series: Eyal Barad, CEO Cannabics Pharmaceuticals",
  "author": "Seeking Alpha",
  "dc:creator": "Seeking Alpha",
  "enclosure": "",
  "guid": "c88a5dadfa94433296168f048b76a4aa",
  "pubDate": "Thu, 18 Apr 2019 11:32:11 GMT",
  "link": "https://the-cannabis-investing-podcast.sounder.fm",
  "description": "<p>Eyal Barad, CEO Cannabics Pharmaceuticals, talked with Rena Sherbill about the business side of the company, recent volatility in the stock, its investment in Seedo, its joint venture with Wize Pharma and the patents it has in development.\nLearn more about your ad choices. Visit megaphone.fm/adchoices</p>",
  "content:encoded": "<p>Eyal Barad, CEO Cannabics Pharmaceuticals, talked with Rena Sherbill about the business side of the company, recent volatility in the stock, its investment in Seedo, its joint venture with Wize Pharma and the patents it has in development.\nLearn more about your ad choices. Visit megaphone.fm/adchoices</p>",
  "itunes:title": "CannaTech Conference Series: Eyal Barad, CEO Cannabics Pharmaceuticals",
  "itunes:image": "",
  "itunes:author": "Seeking Alpha",
  "itunes:duration": "00:09:53",
  "itunes:explicit": false,
  "itunes:subtitle": "Eyal Barad, CEO Cannabics Pharmaceuticals, talked with Rena Sherbill about the business side of the company, recent volatility in the stock, its investment in Seedo, its joint venture with Wize Pharma and the patents it has in development.",
  "itunes:summary": "Eyal Barad, CEO Cannabics Pharmaceuticals, talked with Rena Sherbill about the business side of the company, recent volatility in the stock, its investment in Seedo, its joint venture with Wize Pharma and the patents it has in development.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "itunes:episodeType": "full",
  "podcast:person": "Seeking Alpha",
  "podcast:transcript": "",
  "podcast:guid": "c88a5dadfa94433296168f048b76a4aa"
}